HDAC6 and colorectal carcinoma: HDAC6 knockdown reduced CRC cell viability, colony formation, and migration; furthermore, HDAC6 inhibition partially inhibited the growth and migration of CRC cells through the mitogen-activated protein kinase/extracellular signal–regulated kinase (MAPK/ERK) pathway.